Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update

OBJECTIVE: A previous phase-2 trial to assess the addition of Endostar to gemcitabine and cisplatin (GC) chemotherapy showed that it improves prognosis in metastatic nasopharyngeal carcinoma (M-NPC) but the study cohort was small. We wished to update that phase-2 trial by enrolling an additional 44...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ting, Jiang, Feng, Jin, Qi-Feng, Piao, Yong-Feng, Chen, Xiao-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884068/
https://www.ncbi.nlm.nih.gov/pubmed/29413761
http://dx.doi.org/10.1016/j.tranon.2018.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884068/
https://www.ncbi.nlm.nih.gov/pubmed/29413761
http://dx.doi.org/10.1016/j.tranon.2018.01.002

Ejemplares similares